囊性纤维化治疗的新时代:不断变化和适应
Barry L Diener1, Fredy Huertero2, Teresa Stables-Carney1
1Division of Pediatric Pulmonary.
Current opinion in pediatrics
|August 18, 2023
概括
囊性纤维化 (CF) 护理模式正随着新疗法和远程医疗等综合方法的发展而发展. 这种适应确保了CF患者的改善,以患者为中心的慢性疾病管理.
科学领域:
- 肺病学和呼吸系统医学
- 医疗信息学 医疗信息学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 囊性纤维化 (CF) 是一种慢性多系统性疾病,需要专门的多学科护理.
- 在CF护理和治疗方面的进步导致CF患者的寿命延长和健康改善.
- 结核病护理模式需要适应不断变化的患者需求和治疗环境.
研究的目的:
- 审查目前和不断发展的囊性纤维化 (CF) 护理模式.
- 要突出由新疗法和技术进步驱动的CF管理中的适应性.
- 讨论将以患者为中心的方法整合到CF护理中.
主要方法:
- 审查目前的文献和临床实践趋势在囊性纤维化护理.
- 分析新疗法的影响,包括CFTR调节器疗法.
- 检查了远程医疗,远程患者监测和共享决策的整合.
主要成果:
- 结核病护理模式已经适应,结合了针对结核病细胞缺陷的革命性,高效的疗法.
- 远程医疗和远程患者监测已被整合到CF护理中,由COVID-19大流行加速.
- 与患者和家人共同决策和共同生产护理对CF模型的核心地位越来越高.
结论:
- 肺结核治疗模式是动态的,适应科学突破和患者需求.
- 综合先进的疗法和数字健康工具,提高了CF的慢性疾病管理.
- 强调共享决策的协作护理模式改善了CF患者的治疗结果.
相关概念视频
Cystic Fibrosis: Management
194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
194
Cystic Fibrosis: Pathogenesis
280
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
280
Chronic Pancreatitis II: Collaborative Care
113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
113
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Acute Respiratory Failure-V
162
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
162
Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.0K


